Active	Status	Sponsor type	Region	Phase	Filter
5 Active 3 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SANSON, Marc
OPTIMUM, NCT04945148: Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide	Recruiting	2	640	Europe	Metformin, Radiation IMRT, Radiation, Temozolomide	Hopital Foch, National Cancer Institute, France	Glioblastoma, IDH-wildtype	05/28	05/28
ONCONEUROTEK 2, NCT06314607: Genetic and Molecular Characterization of Nervous System Lesions	Recruiting	N/A	10000	NA	Prospective Biological Collection, Retrospective Biological Collection	Assistance Publique - Hôpitaux de Paris	Brain Tumor, Brain Lesion (General)	03/34	03/34
ANDROMEDE-F, NCT04372095: Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study	Recruiting	N/A	2000	Europe	oral smears	Assistance Publique - Hôpitaux de Paris	Meningioma	04/25	04/25
SPECTA, NCT02834884: Screening Cancer Patients for Efficient Clinical Trial Access	Recruiting	N/A	4975	Europe, RoW	RP-1828 IMMUcan, RP-1759 AYA/TYA, RP-1843 Arcagen, RP-1920 BioRadon	European Organisation for Research and Treatment of Cancer - EORTC	All Tumor Types	03/26	03/26
GLIOMRS, NCT05700071: MRS of Glioma Genomics	Recruiting	N/A	80	Europe	MRI	Institut National de la Santé Et de la Recherche Médicale, France	Glioma	03/26	03/28

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SANSON, Marc
OPTIMUM, NCT04945148: Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide	Recruiting	2	640	Europe	Metformin, Radiation IMRT, Radiation, Temozolomide	Hopital Foch, National Cancer Institute, France	Glioblastoma, IDH-wildtype	05/28	05/28
ONCONEUROTEK 2, NCT06314607: Genetic and Molecular Characterization of Nervous System Lesions	Recruiting	N/A	10000	NA	Prospective Biological Collection, Retrospective Biological Collection	Assistance Publique - Hôpitaux de Paris	Brain Tumor, Brain Lesion (General)	03/34	03/34
ANDROMEDE-F, NCT04372095: Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study	Recruiting	N/A	2000	Europe	oral smears	Assistance Publique - Hôpitaux de Paris	Meningioma	04/25	04/25
SPECTA, NCT02834884: Screening Cancer Patients for Efficient Clinical Trial Access	Recruiting	N/A	4975	Europe, RoW	RP-1828 IMMUcan, RP-1759 AYA/TYA, RP-1843 Arcagen, RP-1920 BioRadon	European Organisation for Research and Treatment of Cancer - EORTC	All Tumor Types	03/26	03/26
GLIOMRS, NCT05700071: MRS of Glioma Genomics	Recruiting	N/A	80	Europe	MRI	Institut National de la Santé Et de la Recherche Médicale, France	Glioma	03/26	03/28